Search

Phylogica signs Asthma research agreement

Subiaco-based drug development company Phylogica Ltd will allow the Swiss Institute of Allergy & Asthma Research to screen its libraries of proteins for potential vaccine leads under a research collaboration agreement, the company has announced.

Login

(existing subscribers)

The password field is case sensitive.
Request new password

Sign up for free emails

Complete your details below to receive our twice-daily news emails and our BN Weekender.

CAPTCHA
Thanks! This question prevents spammers...
Image CAPTCHA
Enter the characters shown in the image.

Add your comment

Phylogica (PYC)

Share Price

Closing price for the last 90 trading days
Source: Morningstar

Total Shareholder Return as at 29/12/17

1 year TSR5 year TSR
199thPhylogica60%15%
584thResonance Health-19%2%
695thAlgae.Tec-42%-37%
712thCycliq-45%2%
696 WA (and selected non WA) listed companies ranked by 1 year TSR relative to other companies with similar revenue
Source: Morningstar

Share Transactions

04/01/18
$0 Issued
04/01/18
$0 Other
29/11/17
$56k Issued
Total value as at the date of the transaction
Source: Morningstar

Revenue

114th↓Algae.Tec$2.8m
115th↑Phylogica$2.8m
117th-Cycliq$2.5m
118th↓Resonance Health$2.5m
234 listed industrial companies ranked by revenue.
Source: Morningstar

Remuneration from Phylogica

1370thBernard Hockings$44k
1545thStephanie Unwin$26k
Ranked by total remuneration from all listed WA companies

BNiQ Disclaimer